PICC Inserted by a Nurse-led Vascular Access Team in Poland
NIce-PICC
1 other identifier
observational
200
1 country
1
Brief Summary
Implantation of PICCs by a trained, dedicated nursing team can be effective and safe, and allows for intravenous therapy that requires medium- to long-term central venous access.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2025
CompletedFirst Submitted
Initial submission to the registry
May 7, 2025
CompletedFirst Posted
Study publicly available on registry
May 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2026
CompletedApril 27, 2026
March 1, 2026
9 months
May 7, 2025
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
First attempt success rate
First attempt vein puncture defined as single vein puncture and possibility of blood aspiration.
During placement
Secondary Outcomes (6)
Confirmation of tip placement in the lower 1/3 of the superior vena cava at or above the superior vena cava/right atrium junction will be performed by chest x-ray or other tip confirmation system/device and documented
During placement
Percent of PICCs that remain in place through the required therapy time period
90 days
Incidence of symptomatic venous thrombosis in patients with a PICC
90 days
Incidence of Catheter-related Bloodstream Infection
90 days
Occurrence of complications not directly related to the cannulation procedure
90 days
- +1 more secondary outcomes
Study Arms (1)
Patients who requrie a PICC
All subjects patients who requrie a PICC
Interventions
Eligibility Criteria
All subjects patients who require a PICC
You may qualify if:
- Age \>18 years
- Intravenous therapy with solutions requiring central vein cannulation (irritant drugs, extreme pH \<5 and \>9, osmolarity \> 600 mOsm/l), e.g., chemotherapy, parenteral nutrition with osmolarity \>900 mOsm/l
- Difficult intravenous access with multiple blood collection
- Ability to consent to participate in the study
- Consent to participate in the study
You may not qualify if:
- Presence of central venous catheter, such as. centrally inserted central catheter or totally implanted vascular device
- Indication of another type of vascular access device
- Lack of veins suitable for cannulation of the arm
- Infection, burns or other skin lesion on the upper extremities (involving the site of planned catheter insertion and attachment)
- Pregnancy (confirmed by history and review of medical records or confirmed by positive human chorionic gonadotropin (hCG) determination in urine or plasma)
- Lack of patient consent to participate in the study
- Lack of capacity to consent to participate in the study
- No physician present to supervise the procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Warsaw
Warsaw, Poland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2025
First Posted
May 18, 2025
Study Start
May 5, 2025
Primary Completion
January 31, 2026
Study Completion
May 2, 2026
Last Updated
April 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share